ATE226579T1 - Verbesserte verfahren fur assymmetrische hydrogenation - Google Patents

Verbesserte verfahren fur assymmetrische hydrogenation

Info

Publication number
ATE226579T1
ATE226579T1 AT00915771T AT00915771T ATE226579T1 AT E226579 T1 ATE226579 T1 AT E226579T1 AT 00915771 T AT00915771 T AT 00915771T AT 00915771 T AT00915771 T AT 00915771T AT E226579 T1 ATE226579 T1 AT E226579T1
Authority
AT
Austria
Prior art keywords
hydrogenation
assymmetric
improved methods
compound
formula
Prior art date
Application number
AT00915771T
Other languages
English (en)
Inventor
Bradley D Hewitt
Mark J Burk
Nicholas B Johnson
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE226579T1 publication Critical patent/ATE226579T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
AT00915771T 1999-03-18 2000-03-14 Verbesserte verfahren fur assymmetrische hydrogenation ATE226579T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12505199P 1999-03-18 1999-03-18
PCT/US2000/003720 WO2000055150A1 (en) 1999-03-18 2000-03-14 Improved process for asymmetric hydrogenation

Publications (1)

Publication Number Publication Date
ATE226579T1 true ATE226579T1 (de) 2002-11-15

Family

ID=22417991

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00915771T ATE226579T1 (de) 1999-03-18 2000-03-14 Verbesserte verfahren fur assymmetrische hydrogenation

Country Status (11)

Country Link
US (1) US6211386B1 (de)
EP (1) EP1161427B1 (de)
JP (2) JP3610014B2 (de)
AT (1) ATE226579T1 (de)
AU (1) AU3699100A (de)
DE (1) DE60000660T2 (de)
DK (1) DK1161427T3 (de)
ES (1) ES2185582T3 (de)
PT (1) PT1161427E (de)
TW (1) TWI222970B (de)
WO (1) WO2000055150A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0026890D0 (en) * 2000-11-03 2000-12-20 Ici Plc Catalyst
CA2475332A1 (en) 2002-02-07 2003-08-14 Sumitomo Chemical Company, Limited Process for producing (r)-3-hydroxy-3-(2-phenylethyl)hexanoic acid and its intermediate
DE10313118A1 (de) * 2003-03-24 2004-10-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Enantioselektive Hydrierung von Intermediaten bei der Tipranavir-Synthese

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171892A (en) 1991-07-02 1992-12-15 E. I. Du Pont De Nemours And Company Chiral phospholanes via chiral 1,4-diol cyclic sulfates
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
ZA965853B (en) 1995-07-13 1998-01-12 Du Pont Merck Pharma Asymmetric synthesis of r and s warfarin and its analogs.
CZ298847B6 (cs) 1997-09-11 2008-02-27 Pharmacia & Upjohn Company Zpusob výroby proteázového inhibitoru

Also Published As

Publication number Publication date
ES2185582T3 (es) 2003-05-01
EP1161427B1 (de) 2002-10-23
DK1161427T3 (da) 2003-02-24
JP3610014B2 (ja) 2005-01-12
JP4722413B2 (ja) 2011-07-13
US6211386B1 (en) 2001-04-03
JP2002539205A (ja) 2002-11-19
WO2000055150A1 (en) 2000-09-21
DE60000660T2 (de) 2003-06-26
EP1161427A1 (de) 2001-12-12
DE60000660D1 (de) 2002-11-28
PT1161427E (pt) 2003-03-31
AU3699100A (en) 2000-10-04
TWI222970B (en) 2004-11-01
JP2004307511A (ja) 2004-11-04

Similar Documents

Publication Publication Date Title
Zhang et al. Gold (I)-catalyzed enantioselective hydroamination of N-allenyl carbamates
Keith et al. Asymmetric hydrocyanation of hydrazones catalyzed by lanthanide− PYBOX complexes
Reznichenko et al. C 1-Symmetric rare-earth-metal aminodiolate complexes for intra-and intermolecular asymmetric hydroamination of alkenes
KR940013508A (ko) 우울증 및 파킨슨증후군 치료용 화합물
Li et al. Chiral C 2-symmetric ligands with 1, 4-dioxane backbone derived from tartrates: Syntheses and applications in asymmetric hydrogenation
DE60123093D1 (de) Katalysator für asymmetrische hydrogenierung
DE60104825D1 (de) Verfahren zur herstellung von 6-substituierten (s)-nikotin-derivaten und zwischenverbindungen
DE69705035D1 (de) N-Azacycloalkylalkyldibenzothiophencarboxamide: spezifische Liganden für Dopaminrezeptorsubtypen
DE602004010830D1 (de) Verfahren zur herstellung von chiralen propionsäurederivaten
ATE554061T1 (de) Verfahren zur herstellung von aminen
Lygo et al. An enantioselective approach to bis-α-amino acids
DE60000660D1 (de) Verbesserte verfahren fur assymmetrische hydrogenation
DE69912474D1 (de) Verfahren zur racematspaltung von tramadol
ATE399749T1 (de) Verfahren zur hydrierung von methylolalkanalen
DK1047669T3 (da) Perfluor-N-alkylsulfonsyrederivater
SG149776A1 (en) Organic metal compound and process for preparing optically-active alcohols using the same
ATE404282T1 (de) Verfahren zur herstellung von kationischen rhodiumkomplexen
DE69920708D1 (de) Verfahren zur herstellung von 1,4-bis[[2-(dimethylamino)ethyl amino]-5,8-dihydroxyanthracene-9,10-dion
DE602004025935D1 (de) Histondeacetylaseinhibitor und verfahren zu dessen herstellung
WO1999032225A3 (en) Catalytic composition based on chiral ligands with molybdenum, tungsten or chromium and method for asymmetric alkylation of allylic substrates
DE602006011360D1 (de) Katalysiertes verfahren zur herstellung von c-5-substituierten heterocyclischen inhibitoren von 11beta-hydroxysteroiddehydrogenase vom typ 1
ATE284867T1 (de) Verfahren zur herstellung chiraler verbindungen
ATE348830T1 (de) Kryptatverbindungen und verfahren zur diagnose und therapie
ATE401298T1 (de) Verbessertes verfahren zur herstellung von 2s,3s- n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)- - nitrobenzenesulfonylamid hydrochlorid und anderen derivaten von 2-hydroxy-1,3-diamin
BRPI0519272B8 (pt) processo para transição de hidrogenação assimétrica catalisada por metal de transição de derivados do ácido acrílico, sistema catalisador para catálise de metal de transição assimétrico, e uso do sistema catalisador

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1161427

Country of ref document: EP